These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 31630405)

  • 21. Mechanistic Basis of Cabotegravir-Glucuronide Disposition in Humans.
    Patel M; Eberl HC; Wolf A; Pierre E; Polli JW; Zamek-Gliszczynski MJ
    J Pharmacol Exp Ther; 2019 Aug; 370(2):269-277. PubMed ID: 31175220
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitative Characterization of Clinically Relevant Drug-Metabolizing Enzymes and Transporters in Rat Liver and Intestinal Segments for Applications in PBPK Modeling.
    Sharma S; Singh DK; Mettu VS; Yue G; Ahire D; Basit A; Heyward S; Prasad B
    Mol Pharm; 2023 Mar; 20(3):1737-1749. PubMed ID: 36791335
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Investigation of nonalcoholic fatty liver disease-induced drug metabolism by comparative global toxicoproteomics.
    Na AY; Jo JJ; Kwon OK; Shrestha R; Cho PJ; Kim KM; Ki SH; Lee TH; Jeon TW; Jeong TC; Lee S
    Toxicol Appl Pharmacol; 2018 Aug; 352():28-37. PubMed ID: 29792946
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Regional-Specific Relative and Absolute Expression of Gut Transporters in Adult Caucasians: A Meta-Analysis.
    Harwood MD; Zhang M; Pathak SM; Neuhoff S
    Drug Metab Dispos; 2019 Aug; 47(8):854-864. PubMed ID: 31076413
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Renal Transporter Alterations in Patients with Chronic Liver Diseases: Nonalcoholic Steatohepatitis, Alcohol-Associated, Viral Hepatitis, and Alcohol-Viral Combination.
    Frost KL; Jilek JL; Sinari S; Klein RR; Billheimer D; Wright SH; Cherrington NJ
    Drug Metab Dispos; 2023 Feb; 51(2):155-164. PubMed ID: 36328481
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interplay of phase II enzymes and transporters in futile cycling: influence of multidrug resistance-associated protein 2-mediated excretion of estradiol 17beta-D-glucuronide and its 3-sulfate metabolite on net sulfation in perfused TR(-) and Wistar rat liver preparations.
    Sun H; Zeng YY; Pang KS
    Drug Metab Dispos; 2010 May; 38(5):769-80. PubMed ID: 20124397
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantitative transporter proteomics by liquid chromatography with tandem mass spectrometry: addressing methodologic issues of plasma membrane isolation and expression-activity relationship.
    Kumar V; Prasad B; Patilea G; Gupta A; Salphati L; Evers R; Hop CE; Unadkat JD
    Drug Metab Dispos; 2015 Feb; 43(2):284-8. PubMed ID: 25488931
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selectivity in the Efflux of Glucuronides by Human Transporters: MRP4 Is Highly Active toward 4-Methylumbelliferone and 1-Naphthol Glucuronides, while MRP3 Exhibits Stereoselective Propranolol Glucuronide Transport.
    Järvinen E; Troberg J; Kidron H; Finel M
    Mol Pharm; 2017 Oct; 14(10):3299-3311. PubMed ID: 28850245
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatic Disposition of Gemfibrozil and Its Major Metabolite Gemfibrozil 1-O-β-Glucuronide.
    Kimoto E; Li R; Scialis RJ; Lai Y; Varma MV
    Mol Pharm; 2015 Nov; 12(11):3943-52. PubMed ID: 26378985
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Organic Anion Transporting Polypeptide-Mediated Hepatic Uptake of Glucuronide Metabolites of Androgens.
    Li CY; Gupta A; Gáborik Z; Kis E; Prasad B
    Mol Pharmacol; 2020 Sep; 98(3):234-242. PubMed ID: 32587096
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Physiologically Based Pharmacokinetic Modeling of Transporter-Mediated Hepatic Clearance and Liver Partitioning of OATP and OCT Substrates in Cynomolgus Monkeys.
    Morse BL; MacGuire JG; Marino AM; Zhao Y; Fox M; Zhang Y; Shen H; Griffith Humphreys W; Marathe P; Lai Y
    AAPS J; 2017 Nov; 19(6):1878-1889. PubMed ID: 29019117
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Comprehensive Analysis of Ontogeny of Renal Drug Transporters: mRNA Analyses, Quantitative Proteomics, and Localization.
    Cheung KWK; van Groen BD; Spaans E; van Borselen MD; de Bruijn ACJM; Simons-Oosterhuis Y; Tibboel D; Samsom JN; Verdijk RM; Smeets B; Zhang L; Huang SM; Giacomini KM; de Wildt SN
    Clin Pharmacol Ther; 2019 Nov; 106(5):1083-1092. PubMed ID: 31127606
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transporter-Enzyme Interplay: Deconvoluting Effects of Hepatic Transporters and Enzymes on Drug Disposition Using Static and Dynamic Mechanistic Models.
    Varma MV; El-Kattan AF
    J Clin Pharmacol; 2016 Jul; 56 Suppl 7():S99-S109. PubMed ID: 27385183
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Utility of Quantitative Proteomics for Enhancing the Predictive Ability of Physiologically Based Pharmacokinetic Models Across Disease States.
    Sharma S; Suresh Ahire D; Prasad B
    J Clin Pharmacol; 2020 Oct; 60 Suppl 1():S17-S35. PubMed ID: 33205430
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vivo visualization and quantification of (Disturbed) Oatp-mediated hepatic uptake and Mrp2-mediated biliary excretion of 99mTc-mebrofenin in mice.
    Neyt S; Huisman MT; Vanhove C; De Man H; Vliegen M; Moerman L; Dumolyn C; Mannens G; De Vos F
    J Nucl Med; 2013 Apr; 54(4):624-30. PubMed ID: 23440558
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In Vitro Interactions of Epacadostat and its Major Metabolites with Human Efflux and Uptake Transporters: Implications for Pharmacokinetics and Drug Interactions.
    Zhang Q; Zhang Y; Boer J; Shi JG; Hu P; Diamond S; Yeleswaram S
    Drug Metab Dispos; 2017 Jun; 45(6):612-623. PubMed ID: 28283500
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Kidney Cortical Transporter Expression across Species Using Quantitative Proteomics.
    Basit A; Radi Z; Vaidya VS; Karasu M; Prasad B
    Drug Metab Dispos; 2019 Aug; 47(8):802-808. PubMed ID: 31123036
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Analysis of xenobiotic detoxification system mediated by efflux transporters].
    Suzuki H
    Yakugaku Zasshi; 1999 Nov; 119(11):822-34. PubMed ID: 10590710
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Construction of triple-transfected cells [organic anion-transporting polypeptide (OATP) 1B1/multidrug resistance-associated protein (MRP) 2/MRP3 and OATP1B1/MRP2/MRP4] for analysis of the sinusoidal function of MRP3 and MRP4.
    Hirouchi M; Kusuhara H; Onuki R; Ogilvie BW; Parkinson A; Sugiyama Y
    Drug Metab Dispos; 2009 Oct; 37(10):2103-11. PubMed ID: 19628752
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diclofenac and Its Acyl Glucuronide: Determination of In Vivo Exposure in Human Subjects and Characterization as Human Drug Transporter Substrates In Vitro.
    Zhang Y; Han YH; Putluru SP; Matta MK; Kole P; Mandlekar S; Furlong MT; Liu T; Iyer RA; Marathe P; Yang Z; Lai Y; Rodrigues AD
    Drug Metab Dispos; 2016 Mar; 44(3):320-8. PubMed ID: 26714763
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.